Interferon-γ Underlying Thymoma-Associated Immune Dysregulation
Year: 2026
Type: article
Abstract: In an observational study, thymoma-associated immune dysregulation was characterized by interferon-γ pathway activation. Four patients with severe disease treated with Janus kinase 1/2 inhibitors had clinical and biomarker responses.
Source: New England Journal of Medicine
DOI: 10.1056/nejmc2607434
Authors: Iivo Hetemäki, Chen Wang, Rachel Wu, Joseph Pechacek, Taura Webb, Deanna Riley, Lucas dos Santos Dias, Heather Moorman, Princess Barber, Lindsey B. Rosen, Annalie Harris, Sebastian Ochoa, Karthik Darma, Maria Semenova, Laercio Lopez Da Silva, Kai Kisand, Tovah E. Markowitz, Peter D. Burbelo, Monika Fischer, Mark Raffeld, Tyler Hulett, Jennifer Stoddard, Sergio D. Rosenzweig, Christopher G. Kanakry, Kathy L. McGraw, Joseph Rocco, Luigi D. Notarangelo, Christa S. Zerbe, Ivan Fuss, Anjali Rai, Theo Heller, Patrick J. Loehrer, Eliisa Kekäläinen, Alexandra F. Freeman, Arun Rajan, Timi Martelius, Katherine R. Calvo, Steven M. Holland, Roderick Marion, Stefania Pittaluga, Michail S. Lionakis
Institutions: National Institute of Allergy and Infectious Diseases, National Institutes of Health, National Cancer Institute, Bristol Royal Hospital for Children, University of Helsinki, University of Tartu, National Institute of Dental and Craniofacial Research, Indiana University Indianapolis, National Institutes of Health Clinical Center, National Institute of Diabetes and Digestive and Kidney Diseases
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Award: G61876769
OpenAlex ID: W7225798538
